Association between cilostazol and lower limb events after EVT for femoropopliteal artery lesions in CLTI patients: the LANDMARK registry
The LANDMARK registry shows that cilostazol is effective in preventing lower limb events in patients with chronic limb-threatening ischemia(CLTI)undergoing EVT, according to a study reported by Dr. Kazuki Tobita of Shonan Kamakura General Hospital, in the Featured Research Session at the 88th Annual Scientific Meeting of the Japanese Circulation Society.
- Free Registration
-
Already have an account?Log In
A portal site of complex catheter intervention techniques
TCROSS NEWS Global is an online medical journal that provides
valuable information on Cardiovascular medicine to medical professionals
worldwide.
We bring you the latest findings and trends in all areas of
cardiovascular medicine. Please register and subscribe for unlimited access to
quality Cardiovascular News!
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.